Clinical Trial Update: Halting Nucleoside Analogues in Chronic Hepatitis B [NA]

View source ↗

Summary

Clinical trial update regarding stopping nucleoside analogue therapy for chronic hepatitis B; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Seng Gee Lim | Conditions: Chronic Hepatitis B | NA | Status: ACTIVE_NOT_RECRUITING